A trial of contraceptive methods in women with systemic lupus erythematosus
Article Abstract:
A single blind clinical trial is conducted involving 162 women with systemic lupus erythematosus who were randomly assigned to combined oral contraceptives, a progestin-only pill or a copper intrauterine device (IUD). Results show that although estrogen-containing oral-contraceptive regimen do not appear to increase the risk of disease exacerbation in women with systemic lupus erythematosus, one should still be cautious about the possibility of an increased risk of thrombosis with hormonal methods of contraception.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Thinking outside the box
Article Abstract:
The case of a 35-year-old man with advanced acquired immunodeficiency syndrome (AIDS) is used to highlight the challenges clinicians face in the diagnosis of acute pulmonary embolism. The case illustrates the importance of 'thinking outside the box' in order to avoid missing this diagnosis, particularly in patients whose underlying diseases might otherwise suggest alternative explanations for presenting symptoms.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Antibodies to DNA. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus
- Abstracts: CYP2C19 genotype does not represent a genetic predisposition in idiopathic systemic lupus erythematosus. Paradoxical effect of prostacyclin infusion in a patient with primary pulmonary hypertension: A case report
- Abstracts: The role of voice-activated technology in today's dental practice. Postural orthostatic tachycardia syndrome: dental treatment considerations
- Abstracts: Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene